See what questions
a doctor would ask.
A new vaccine for advanced prostate cancer suffererss improves their survival rate. The makers of the vaccine have applied for FDA approval. Its competitor, Taxotere, produced poorer survival rates during trials. In the US, 200,000 men are diagnosed with prostate cancer each year and over 30,000 die from it each year.
Source: summary of medical news story as reported by Health Talk
About: Prostate cancer vaccine improves survival rates
Date: 31 October 2004
Source: Health Talk
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City